It started with a message: how Mutala’s story sparked change in The Gambia

It started with a message: how Mutala’s story sparked change in The Gambia

In April 2015, Mafaal Saidy, a father from The Gambia, reached out to the World Federation of Hemophilia (WFH) with a simple but urgent message: his young son, Mutala, was suffering from painful, persistent bleeds and not responding to his hemophilia A treatment. That single request marked the beginning of an extraordinary journey for the boy, his parents, and the bleeding disorders community in The Gambia.

Also available in: Français Español

The World Federation of Hemophilia (WFH) immediately responded to Mafaal Saidy’s message. A member of the WFH Humanitarian Aid Program team contacted him directly and advised him to take his son to Dakar, Senegal, where he could be seen by Saliou Diop, MD, Director of the Blood Transfusion Centre there.

In Dakar, new tests revealed that Mutala had been misdiagnosed. He didn’t have hemophilia A, as initially believed—he had hemophilia B. With the correct diagnosis, he started receiving the correct treatment product, donated by the WFH Humanitarian Aid Program. The bleeding stopped, and for the first time in weeks, Mutala was pain-free.

Diop gave Mafaal a supply of factor IX to take home, and the WFH continued to follow up with the boy, even covering travel expenses so he could return for check-ups. Six months later, his health was stable—and he had not experienced a single bleed.

This exceptional level of care was made possible thanks to the generous support of donors like you. Without access to accurate diagnosis, donated treatment products, and trained physicians, Mutala’s story might have ended very differently.

Change in The Gambia is taking place because of a concerted, long-term effort by the WFH and by local organizations. In 2019, the Safe Motherhood and Hemophilia Foundation The Gambia was officially established. With WFH’s support, the foundation was accredited as a national member organization (NMO) during the WFH 2022 General Assembly. Working closely with the NMO, the WFH helped train two hemophilia care professionals, establish a working hemophilia treatment centre (HTC) and identify 16 patients.

The WFH Humanitarian Aid Program has also contributed significantly to the country, providing 700,000 IU of factor VIII and 200,000 IU of factor IX to The Gambia between 2021 and 2025. That generosity has enabled physicians to treat increasingly complex cases and effectively manage bleeding episodes. By 2025, the number of diagnosed patients in The Gambia had more than doubled.

Today, the NMO is participating in the WFH Twinning Program with Hemophilia of Georgia (U.S.A), with the goal of strengthening their organizational capacity, improving services for patients and families, and fostering lasting collaboration and knowledge exchange. The Twinning experience has already achieved remarkable milestones:

Now ten years old, Mutala lives a near-normal life, and access to donated factor IX has kept him safe and has kept his condition stable.

I would like to thank the WFH for all the medications I receive for my treatment, I do not know what I would have done without your help.

—Mutala Saidy, boy with hemophilia A, The Gambia

The generosity of our sponsors is not just providing medication, it is building care infrastructure, training professionals, and empowering communities. It is a beautiful reminder that your generosity and compassion changes lives.

Every donation brings us closer to a future where children like Mutala can live full, healthy lives—where diagnosis is no longer delayed, and treatment is never out of reach.

Please support our annual fundraising campaign today so that the WFH can continue this crucial work across the globe.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.